These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 3028438
21. First dose response and 24-hour antihypertensive efficacy of the new once-daily angiotensin converting enzyme inhibitor, ramipril. Heber ME, Brigden GS, Caruana MP, Lahiri A, Raftery EB. Am J Cardiol; 1988 Aug 01; 62(4):239-45. PubMed ID: 2969671 [Abstract] [Full Text] [Related]
23. Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial. Mroczek WJ. J Cardiovasc Pharmacol; 1991 Apr 24; 18 Suppl 2():S147-9. PubMed ID: 1725028 [Abstract] [Full Text] [Related]
24. A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo. Villamil AS, Cairns V, Witte PU, Bertolasi CA. Am J Cardiol; 1987 Apr 24; 59(10):110D-114D. PubMed ID: 3034017 [Abstract] [Full Text] [Related]
25. Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat. Bünning P. Arzneimittelforschung; 1984 Apr 24; 34(10B):1406-10. PubMed ID: 6097266 [Abstract] [Full Text] [Related]
26. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats. Moursi MG, Ganten D, Lang RE, Unger T. J Hypertens Suppl; 1986 Oct 24; 4(3):S495-8. PubMed ID: 3023591 [Abstract] [Full Text] [Related]
27. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)]. Unger T, Moursi MG, Lebrun C, Ganten D, Lang RE. Arch Mal Coeur Vaiss; 1986 Jun 24; 79(6):971-4. PubMed ID: 3026275 [Abstract] [Full Text] [Related]
28. Dose-response relationship of ramipril in patients with mild-to-moderate hypertension. Schnaper HW. J Cardiovasc Pharmacol; 1991 Jun 24; 18 Suppl 2():S128-30. PubMed ID: 1725021 [Abstract] [Full Text] [Related]
29. Effect of ramipril on 24-hour variability of blood pressure and heart rate in essential hypertension. Tochikubo O, Asahina S, Kaneko Y. Am J Cardiol; 1987 Apr 24; 59(10):83D-85D. PubMed ID: 3034039 [Abstract] [Full Text] [Related]
30. Pharmacodynamic effects of a single 10-mg dose of the angiotensin converting enzyme inhibitor ramipril in patients with impaired renal function. Ocón-Pujadas J, Debusmann ER, Jane F, Lahn W, Irmisch R, Mora J, Grötsch H. J Cardiovasc Pharmacol; 1989 Apr 24; 13 Suppl 3():S45-8. PubMed ID: 2474101 [Abstract] [Full Text] [Related]
31. [Long-term blood pressure measurement for evaluating the first dose response of captopril and ramipril in patients with a stimulated renin system]. Lüders S, Schrader J, Schoel G, Ruschitzka F, Scheler F. Z Kardiol; 1992 Apr 24; 81 Suppl 2():41-4. PubMed ID: 1387500 [Abstract] [Full Text] [Related]
32. Influence of the new angiotensin converting enzyme inhibitor ramipril on several models of acute inflammation and the adjuvant arthritis in the rat. Caspritz G, Alpermann HG, Schleyerbach R. Arzneimittelforschung; 1986 Nov 24; 36(11):1605-8. PubMed ID: 3028436 [Abstract] [Full Text] [Related]
33. An open multicenter study to assess the long-term efficacy, tolerance, and safety of the oral angiotensin converting enzyme inhibitor ramipril in patients with mild to moderate essential hypertension. Bauer B, Lorenz H, Zahlten R. J Cardiovasc Pharmacol; 1989 Nov 24; 13 Suppl 3():S70-4. PubMed ID: 2474109 [Abstract] [Full Text] [Related]
34. A radioimmunoassay for the angiotensin converting enzyme inhibitor ramipril and its active metabolite. Eckert HG, Münscher G, Oekonomopulos R, Strecker H, Urbach H, Wissmann H. Arzneimittelforschung; 1985 Nov 24; 35(8):1251-6. PubMed ID: 3000393 [Abstract] [Full Text] [Related]
35. Ramipril for hypertension secondary to renal artery stenosis. Changes in blood pressure, the renin-angiotensin system and total and divided renal function. Tillman DM, Adams FG, Gillen G, Morton JJ, Robertson JI. Am J Cardiol; 1987 Apr 24; 59(10):133D-142D. PubMed ID: 3034022 [Abstract] [Full Text] [Related]
36. Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension. Witte PU, Walter U. Am J Cardiol; 1987 Apr 24; 59(10):115D-120D. PubMed ID: 3034018 [Abstract] [Full Text] [Related]
37. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives. Iimura O, Shimamoto K. Adv Exp Med Biol; 1989 Apr 24; 247A():39-48. PubMed ID: 2532450 [Abstract] [Full Text] [Related]
38. Therapeutic efficacy and tolerance of ramipril in hypertensive patients with renal failure. Kindler J, Schunkert H, Gassmann M, Lahn W, Irmisch R, Debusmann ER, Ocón-Pujadas J, Ritz E, Sieberth HG. J Cardiovasc Pharmacol; 1989 Apr 24; 13 Suppl 3():S55-8. PubMed ID: 2474105 [Abstract] [Full Text] [Related]
39. Effects of ramipril on arterial hemodynamics. Benetos A, Vasmant D, Thiéry P, Safar M. J Cardiovasc Pharmacol; 1991 Apr 24; 18 Suppl 2():S153-6. PubMed ID: 1725030 [Abstract] [Full Text] [Related]
40. 24-hour blood pressure profiles in hypertensive patients administered ramipril or placebo once daily: magnitude and duration of antihypertensive effects. Ramipril Multicenter Study Group. McCarron D. Clin Cardiol; 1991 Sep 24; 14(9):737-42. PubMed ID: 1835914 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]